Drug-eluting beads in hepatocellular carcinoma

Drug-eluting beads in hepatocellular carcinoma

Bibliographic Details
Main Authors:	Hiroyuki Abe, Kenya Kamimura, Shuji Terai
Format:	Article
Language:	English
Published:	SAGE Publishing 2017-03-01
Series:	Therapeutic Advances in Gastroenterology
Online Access:	https://doi.org/10.1177/1756283X16681710

Similar Items

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302
by: Masafumi Ikeda, et al.
Published: (2022-06-01)

Advances in the treatment of hepatocellular carcinoma using drug-eluting beads
by: Guangxu Wei, et al.
Published: (2020-09-01)

Rare complication of hepatocellular carcinoma in Wilson's disease
by: Marina Ohkoshi‐Yamada, et al.
Published: (2021-10-01)

Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma
by: Yusuke Imai, MD, et al.
Published: (2017-03-01)

Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?
by: Sieh-Yang Lee, et al.
Published: (2020-05-01)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Kazue Shiozawa, et al.
Published: (2014-11-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads in Hepatocellular Carcinoma: A Single-Center Experience
by: Erbil Arık, et al.
Published: (2022-08-01)

Transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma: response analysis with mRECIST
by: Claudia Domaratius, et al.
Published: (2021-01-01)

Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Guoliang Shao, et al.
Published: (2022-10-01)

Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)
by: Liu YS, et al.
Published: (2022-08-01)

Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Wang TC, et al.
Published: (2020-03-01)

Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma
by: Mohammad Arabi, et al.
Published: (2015-01-01)

BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
by: Hiroyuki Abe, et al.
Published: (2023-07-01)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023-08-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment
by: Emanuele Boatta, et al.
Published: (2013-04-01)

Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
by: Zi-shu Zhang, et al.
Published: (2019-11-01)

Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma
by: Kenya Kamimura, et al.
Published: (2020-02-01)

Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound
by: Kazue Shiozawa, et al.
Published: (2021-02-01)

Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
by: Ji K, et al.
Published: (2022-06-01)

In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
by: Steven Lahti, et al.
Published: (2017-01-01)

Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma
by: Jeong Yeop Lee, et al.
Published: (2021-12-01)

Selective doxorubicin drug eluting beads chemoembolization of hypovascular hepatocellular carcinoma using cone beam computed tomography
by: Naveen Kalra, et al.
Published: (2012-10-01)

Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma
by: Murtuza Razi, et al.
Published: (2021-02-01)

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
by: Chang WC, et al.
Published: (2021-08-01)

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
by: Hao Li, et al.
Published: (2023-12-01)

Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Khalid I. Bzeizi, et al.
Published: (2021-12-01)

Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning
by: Leonardo Guedes Moreira Valle, et al.
Published: (2023-10-01)

Does drug-eluting bead transcatheter arterial chemoembolization improve the management of patients with hepatocellular carcinoma? A meta-analysis.
by: Shilong Han, et al.
Published: (2014-01-01)

The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus
by: Weihua Zhang, et al.
Published: (2022-04-01)

Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?
by: Dimitri Dorcaratto, et al.
Published: (2017-11-01)

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma
by: Chiu SH, et al.
Published: (2020-11-01)

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
by: Huang J, et al.
Published: (2021-11-01)

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
by: Fidelman N, et al.
Published: (2019-06-01)

Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study
by: Shi Q, et al.
Published: (2020-07-01)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
by: Kobayashi S, et al.
Published: (2020-10-01)

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
by: Waleed M. Hetta, et al.
Published: (2014-09-01)

Advances in the Treatment of Gastrointestinal Bleeding: Safety and Efficiency of Transnasal Endoscopy
by: Hiroyuki Abe, et al.
Published: (2021-09-01)